Dennig J, Beato M, Suske G
Institut für Molekularbiologie und Tumorforschung, Germany.
EMBO J. 1996 Oct 15;15(20):5659-67.
Sp3 is a ubiquitously expressed human transcription factor closely related to Sp1 and Sp4. All three proteins contain a highly conserved DNA binding domain and two glutamine-rich regions, suggesting that they possess similar activation functions. In our previous experiments, however, Sp3 failed to activate transcription. Instead, it repressed Sp1-mediated transcriptional activation, suggesting that it is an inhibitory member of this family of regulatory factors. Here we show that Sp3 can also act as a positive regulator of transcription. The glutamine-rich domains on their own have a strong activation function and interact with the TATA box binding protein (TBP)-associated factor dTAFII110. However, in full-length Sp3 as well as in Gal4-Sp3 fusion proteins, both activation domains are silenced by an inhibitory domain located between the second glutamine-rich region and the DNA binding domain. The inhibitory domain completely suppressed transcriptional activation when fused to a heterologous glutamine-rich domain but only moderately suppressed transcription when linked to an acidic activation domain. Site-directed mutagenesis identified a stretch of highly charged amino acid residues essential for inhibitor function. Substitution of the amino acid triplet KEE by alanine residues within this region changed the almost transcriptionally inactive Sp3 into a strong activator. Our results suggest that the transcriptional activity of Sp3 might be regulated in vivo by relief of inhibition.
Sp3是一种在人体中广泛表达的转录因子,与Sp1和Sp4密切相关。这三种蛋白质都含有一个高度保守的DNA结合结构域和两个富含谷氨酰胺的区域,这表明它们具有相似的激活功能。然而,在我们之前的实验中,Sp3未能激活转录。相反,它抑制了Sp1介导的转录激活,这表明它是这个调节因子家族的一个抑制性成员。在这里,我们表明Sp3也可以作为转录的正调节因子。富含谷氨酰胺的结构域本身具有很强的激活功能,并与TATA盒结合蛋白(TBP)相关因子dTAFII110相互作用。然而,在全长Sp3以及Gal4-Sp3融合蛋白中,两个激活结构域都被位于第二个富含谷氨酰胺区域和DNA结合结构域之间的一个抑制结构域所沉默。当与异源富含谷氨酰胺的结构域融合时,抑制结构域完全抑制转录激活,但当与酸性激活结构域相连时,仅适度抑制转录。定点诱变确定了一段对抑制功能至关重要的高电荷氨基酸残基。将该区域内的氨基酸三联体KEE替换为丙氨酸残基,使几乎无转录活性的Sp3变成了一个强激活剂。我们的结果表明,Sp3的转录活性可能在体内通过解除抑制来调节。